Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) Return on Sales (2016 - 2025)

Iradimed (IRMD) has disclosed Return on Sales for 13 consecutive years, with 0.4% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 142.0% to 0.4% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.3% through Dec 2025, up 38.0% year-over-year, with the annual reading at 0.3% for FY2025, 38.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.4% at Iradimed, up from 0.26% in the prior quarter.
  • The five-year high for Return on Sales was 0.4% in Q4 2025, with the low at 1.02% in Q4 2024.
  • Average Return on Sales over 5 years is 0.19%, with a median of 0.26% recorded in 2022.
  • The sharpest move saw Return on Sales tumbled -128bps in 2024, then surged 142bps in 2025.
  • Over 5 years, Return on Sales stood at 0.37% in 2021, then tumbled by -33bps to 0.25% in 2022, then grew by 5bps to 0.26% in 2023, then plummeted by -492bps to 1.02% in 2024, then surged by 140bps to 0.4% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.4%, 0.26%, and 0.28% for Q4 2025, Q3 2025, and Q2 2025 respectively.